4D Molecular Therapeutics, Inc. (FDMT)
NASDAQ: FDMT · Real-Time Price · USD
9.18
-0.05 (-0.54%)
Mar 24, 2026, 4:00 PM EDT - Market closed
4D Molecular Therapeutics Analyst Ratings
Total Analysts
6
Consensus Rating
Strong Buy
Price Target
$33.50
Upside
+264.92%
Ratings History
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy Reiterates $36 | Strong Buy | Reiterates | $36 | +292.16% | Mar 20, 2026 |
| RBC Capital | RBC Capital | Buy Maintains $32 → $35 | Buy | Maintains | $32 → $35 | +281.26% | Mar 19, 2026 |
| Chardan Capital | Chardan Capital | Strong Buy Maintains $26 | Strong Buy | Maintains | $26 | +183.22% | Mar 19, 2026 |
| Barclays | Barclays | Buy Initiates $33 | Buy | Initiates | $33 | +259.48% | Jan 28, 2026 |
| Chardan Capital | Chardan Capital | Strong Buy Maintains $26 | Strong Buy | Maintains | $26 | +183.22% | Dec 18, 2025 |
| RBC Capital | RBC Capital | Buy Maintains $26 → $32 | Buy | Maintains | $26 → $32 | +248.58% | Nov 11, 2025 |
| Barclays | Barclays | Buy Maintains $38 → $33 | Buy | Maintains | $38 → $33 | +259.48% | Nov 11, 2025 |
| Chardan Capital | Chardan Capital | Strong Buy Maintains $25 → $26 | Strong Buy | Maintains | $25 → $26 | +183.22% | Nov 11, 2025 |
| RBC Capital | RBC Capital | Buy Reiterates $26 | Buy | Reiterates | $26 | +183.22% | Oct 21, 2025 |
| Roth Capital | Roth Capital | Strong Buy Maintains $44 → $38 | Strong Buy | Maintains | $44 → $38 | +313.94% | Aug 12, 2025 |
| Chardan Capital | Chardan Capital | Strong Buy Maintains $25 | Strong Buy | Maintains | $25 | +172.33% | Aug 12, 2025 |
| Chardan Capital | Chardan Capital | Strong Buy Maintains $25 | Strong Buy | Maintains | $25 | +172.33% | Aug 1, 2025 |
| Chardan Capital | Chardan Capital | Strong Buy Maintains $25 | Strong Buy | Maintains | $25 | +172.33% | Jul 3, 2025 |
| Chardan Capital | Chardan Capital | Strong Buy Maintains $28 → $25 | Strong Buy | Maintains | $28 → $25 | +172.33% | May 9, 2025 |
| Goldman Sachs | Goldman Sachs | Strong Buy Maintains $51 → $44 | Strong Buy | Maintains | $51 → $44 | +379.30% | May 9, 2025 |
| Barclays | Barclays | Buy Maintains $45 → $38 | Buy | Maintains | $45 → $38 | +313.94% | May 9, 2025 |
Upgrade to Pro
Get stock forecasts from Wall Street's highest rated professionals
Get much more with Stock Analysis Pro
- Investment ideas from the top Wall Street analysts
- Unlimited access to all data and tools
- Advanced analyst filtering and sorting options
- Up to 10 years of analyst rating history
Analyst Star Rankings
Our analyst star rankings are based on these four factors
- Success Rate
- The percentage of ratings that are profitable.
- Average Return
- The average percentage return within one year of the rating.
- Rating Count
- The more ratings the analyst has provided, the higher the score.
- Recency
- Ratings provided within the past year contribute to a higher score.